Rhomboid Intercostal and Subserratum Plane Block for Minimally Invasive Esophagectomy
Esophagus Cancer
About this trial
This is an interventional treatment trial for Esophagus Cancer focused on measuring Rhomboid intercostal and subserratum plane block, Ultrasound-guided, Postoperative analgesia, Minimally invasive esophagectomy
Eligibility Criteria
Inclusion Criteria: Patients received MIE-McKeown surgery and were confirmed by postoperative pathology; Age 18-75 years old body mass index (BMI) : 18.5~23.9kg/m2; American Society of Anesthesiologists (ASA) grade: Ⅰ~Ⅱ; Clear consciousness, no cognitive impairment; Patients informed to participate in the study and signed informed consent. Exclusion Criteria: Infection of the puncture site, abnormal platelet or coagulation function; Patients with drug allergy involved in this study; Long-term use of analgesic, sedative drugs or a history of heavy drinking; Patients with chronic painful diseases; With severe heart, liver, kidney and lung dysfunction; Infectious diseases, blood, immune, circulatory system diseases; -Communication barriers, can not cooperate with the scale assessment; - Other situations not suitable for this study.
Sites / Locations
- FulingCHRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
Active Comparator
continuous RISS group
single RISS group
PCIA group
Patients were given continuous RISS plane block in addition to patient controlled intravenous analgesia.
Patients were given single RISS plane block in addition to patient controlled intravenous analgesia.
Patients were given patient controlled intravenous analgesia.